500 related articles for article (PubMed ID: 23810807)
21. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.
Zhu Y; Zhang L; Gidday JM
Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330
[TBL] [Abstract][Full Text] [Related]
22. Expression and activation of mitogen-activated protein kinases in the optic nerve head in a rat model of ocular hypertension.
Mammone T; Chidlow G; Casson RJ; Wood JPM
Mol Cell Neurosci; 2018 Apr; 88():270-291. PubMed ID: 29408550
[TBL] [Abstract][Full Text] [Related]
23. Prolonged elevation of intraocular pressure results in retinal ganglion cell loss and abnormal retinal function in mice.
Khan AK; Tse DY; van der Heijden ME; Shah P; Nusbaum DM; Yang Z; Wu SM; Frankfort BJ
Exp Eye Res; 2015 Jan; 130():29-37. PubMed ID: 25450059
[TBL] [Abstract][Full Text] [Related]
24. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma.
Ebneter A; Chidlow G; Wood JP; Casson RJ
Arch Ophthalmol; 2011 Oct; 129(10):1337-44. PubMed ID: 21987677
[TBL] [Abstract][Full Text] [Related]
25. Reversal of functional loss in a rat model of chronic intraocular pressure elevation.
Liu HH; He Z; Nguyen CT; Vingrys AJ; Bui BV
Ophthalmic Physiol Opt; 2017 Jan; 37(1):71-81. PubMed ID: 27774623
[TBL] [Abstract][Full Text] [Related]
26. Elevated intraocular pressure causes inner retinal dysfunction before cell loss in a mouse model of experimental glaucoma.
Frankfort BJ; Khan AK; Tse DY; Chung I; Pang JJ; Yang Z; Gross RL; Wu SM
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):762-70. PubMed ID: 23221072
[TBL] [Abstract][Full Text] [Related]
27. Elevated ocular pressure reduces voltage-gated sodium channel NaV1.2 protein expression in retinal ganglion cell axons.
Risner ML; McGrady NR; Pasini S; Lambert WS; Calkins DJ
Exp Eye Res; 2020 Jan; 190():107873. PubMed ID: 31734278
[TBL] [Abstract][Full Text] [Related]
28. Oral administration of a dual ET
Kodati B; McGrady NR; Jefferies HB; Stankowska DL; Krishnamoorthy RR
Mol Vis; 2022; 28():165-177. PubMed ID: 36274816
[TBL] [Abstract][Full Text] [Related]
29. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model.
Hong S; Kim CY; Lee WS; Shim J; Yeom HY; Seong GJ
Exp Eye Res; 2010 Jan; 90(1):97-103. PubMed ID: 19782071
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma.
Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of optic nerve damage induced by chronic intraocular hypertension in rat.
Wang J; Ge J; Sadun AA; Lam TT
Yan Ke Xue Bao; 2004 Mar; 20(1):25-9. PubMed ID: 15124530
[TBL] [Abstract][Full Text] [Related]
32. A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy.
Ben Simon GJ; Bakalash S; Aloni E; Rosner M
Am J Ophthalmol; 2006 Jun; 141(6):1105-11. PubMed ID: 16765680
[TBL] [Abstract][Full Text] [Related]
33. Development and characterization of a new rat ocular hypertension model induced by intracameral injection of conjunctival fibroblasts.
Nakagawa A; Sakai O; Tokushige H; Fujishiro T; Aihara M
Sci Rep; 2019 Apr; 9(1):6593. PubMed ID: 31036934
[TBL] [Abstract][Full Text] [Related]
34. Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury.
Shaw PX; Sang A; Wang Y; Ho D; Douglas C; Dia L; Goldberg JL
Exp Eye Res; 2017 May; 158():33-42. PubMed ID: 27443501
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of intraocular pressure elevation in a modified laser-induced glaucoma rat model.
Biermann J; van Oterendorp C; Stoykow C; Volz C; Jehle T; Boehringer D; Lagrèze WA
Exp Eye Res; 2012 Nov; 104():7-14. PubMed ID: 22981807
[TBL] [Abstract][Full Text] [Related]
36. Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse.
Chen H; Wei X; Cho KS; Chen G; Sappington R; Calkins DJ; Chen DF
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):36-44. PubMed ID: 20702815
[TBL] [Abstract][Full Text] [Related]
37. Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model.
Abdul Y; Akhter N; Husain S
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1816-28. PubMed ID: 23404122
[TBL] [Abstract][Full Text] [Related]
38. PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection.
Husain S; Ahmad A; Singh S; Peterseim C; Abdul Y; Nutaitis MJ
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6489-6499. PubMed ID: 29288267
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
